Get more information on Microfluidics Market - Request Sample Report
The Microfluidics Market Size was valued at USD 27.86 billion in 2023 and is expected to reach USD 92.43 billion by 2032, growing at a CAGR of 14.29% from 2024-2032.
The microfluidics market is growing rapidly due to the increased need for fast, low-cost diagnostic tools and precision healthcare solutions. Microfluidic devices, for example, lab-on-a-chip and point-of-care testing systems are most critical to making rapid diagnostics that cater to a U.S. Diagnostic & Medical Laboratories market worth USD 79.4 billion in 2023 alone. With more than 5,500 pharmaceutical companies actively conducting R&D worldwide, microfluidics-based technologies help in scalable health solutions. Microfluidics offers maximum efficiency in biochemical analyses for complex analyses with small samples, thus fueling clinical diagnostics and research growth.
Microfluidics is anticipated to propel major progress in personalized medicine and drug development, with worldwide R&D funding exceeding USD 301 billion in 2023. Pharmaceutical firms are progressively utilizing microfluidic technologies to lower drug discovery expenses by as much as 70% via AI. This advancement also enables real-time cellular evaluation in cancer studies and immunotherapy, permitting highly customized treatments. With the increasing demand for precision medicine, microfluidics will be essential in influencing the future of healthcare.
Applications of microfluidics go beyond health sectors, and applications grow in environmental monitoring, wearable health devices, and food safety testing. In 2023, some 40% of US adults engaged in health-related apps, and 35% used wearable devices. Moreover, more people will be integrating themselves into digital health with 75% of the healthcare professionals favorable for AI integration. Microfluidics-enabled devices with AI and machine learning will be integrated for advanced data analysis and automation. This convergence of technology and healthcare positions the microfluidics market for sustained, multi-industry growth.
Drivers
Rising Chronic Disease Burden Propels Demand for Microfluidics Solutions in Healthcare
The more than half a billion individuals suffering from diabetes and heart/circulatory diseases accounting for nearly one-third of deaths worldwide shows an increase in the need for sophisticated diagnostic and monitoring tools. In the United States, 1.9 million new cancer cases, along with over 600,000 cancer deaths, are estimated for 2023, further adding to the need for early detection and personalized treatment. Microfluidics-based technologies open the way for fast, accurate, and minimally invasive testing, especially for chronic conditions, and hence form a fine management strategy for chronic diseases. With management by disease efficiency gaining center stage in health care, microfluidics, no doubt, will be the bedrock through which the increased burden of chronic diseases will be coherently addressed.
Expanding Applications of Microfluidics in Environmental and Food Safety Sectors
In the microfluidics market, environmental monitoring, and food safety testing have gained much momentum as there is an immense need for the real-time tracking of pollutants, along with the identification of contaminations in the current scenario. In 2023, there were more than 7.7 million food safety tests reported by FSIS staff; with this kind of surge in demand and requirement for accurate, efficient testing solutions, microfluidic devices- compact yet precise- are bound to find a place that takes precedence in quickly detecting toxins and pathogens from food sources. As the trend is speeding up and making testing faster and more reliable, microfluidics today is evolving as one of the critical technologies in the environmental and food safety sectors to comply with regulatory standards and to sustain. The expanding application is creating market demand for microfluidic solutions.
Restraints
Technical Challenges Hindering Widespread Adoption of Microfluidics Technology
Technical issues have been cited as the largest barrier to full-scale exploitation of microfluidic devices. Replication at scale is difficult because the designs are hard to reproduce at a specific level of detail and the performance is not very consistent. Quality consistency with high-throughput functionality would be another challenge. Such barriers can greatly slow down production and raise costs, putting further demands on scaleability for commercial exploitation of microfluidic technologies. Such technical drawbacks continue to limit the integration of microfluidics in a wide spread of applications, from health applications to environmental testing.
By Application
The medical/healthcare has accounted for the largest share of approximately 85% of total revenue in 2023, as the demand for fast, accurate diagnostics, personalized medicine, and point-of-care testing solutions is continually increasing. The applications provide significant benefits in monitoring diseases, early detection, and development of drug systems. The non-medical segment is expected to witness the highest growth - up to 16.94% CAGR from 2024 to 2032-based on rising applications of microfluidics in environmental monitoring, food safety, and wearable health devices. Non-medical applications are gaining driving momentum due to the growing demand for compact real-time testing technologies from various industries.
By Material
PDMS (polydimethylsiloxane) dominates the microfluidics market, generating around 41% of the revenue in 2023, mainly due to its excellent flexibility, optical clarity, and readiness for micromachining. These properties qualify it for a huge number of applications, such as lab-on-a-chip, biosensors, and more diagnostic tools. The cost-effectiveness of PDMS combined with compatibility with standard microfabrication increases its use significantly. Also, with an expected compound annual growth rate of 15.08% in this segment during 2024 and 2032, this product is quite in demand due to its association with complex diagnostics the developing market for personalized medicine, and research and healthcare applications are also growing. The dominance of PDMS will continue to grow in the market as research and healthcare applications develop.
By Technology
Lab-on-a-chip (LOC) technology was the leader in the microfluidics market in 2023, with the application of around 38% revenue share, mainly attributed to its manifold applications in diagnostics, drug testing, and research, providing compact, cost-effective solutions. With this ability to house multiple laboratory functions in a single device, Lab-on-a-chips are considered pivotal for personalized medicine and point-of-care diagnostics. In the Organs-on-chips category, growth is expected to be at the highest CAGR of 21.61% during the forecast period from 2024 to 2032, this market is increasing demand for more accurate models that can be human-like to test drugs and study diseases. The chips are used to replicate human organ functions and represent alternative methods to testing on animals, resulting in high investment and research interest. High demand with technological advancements is likely to make Organs-on-chips the growth driver in the industry.
North America dominated the microfluidics market in 2023 with a revenue share of approximately 42%, driven by the presence of key players, advanced healthcare infrastructure, and strong research and development investments. The region benefits from a growing demand for point-of-care diagnostics, lab-on-a-chip technologies, and innovations in personalized medicine. The U.S. and Canada, with their well-established healthcare systems, are prime markets for microfluidic-based solutions, contributing to the region's dominance. Government initiatives and academic collaborations further enhance the adoption of microfluidics in healthcare and biotechnology.
The Asia-Pacific region is expected to grow at the highest CAGR of 17.48% from 2024 to 2032, fueled by rapid advancements in healthcare infrastructure and increasing demand for medical diagnostics. Countries like China, Japan, and India are witnessing a rise in investments in biotechnology and medical research, making the region an emerging hub for microfluidics. Additionally, the growing population and increasing focus on affordable healthcare solutions are pushing demand for cost-effective microfluidic devices. This combination of growing demand and technological innovation positions Asia-Pacific as the fastest-growing market for microfluidics in the coming years.
Need any customization research on Microfluidics Market - Enquire Now
In July 2024, Illumina purchased Fluent BioSciences to improve single-cell analysis and multiomics, streamlining the process and removing complicated microfluidic consumables. Fluent's PIPseq™ V technology will be incorporated to allow for quicker, more economical research.
Bio-Rad introduced Celselect Slides 2.0, crafted for enhanced capture of rare cells and circulating tumor cells (CTCs). These slides, designed for use with the Genesis Cell Isolation System, enable enhanced processing of liquid biopsy specimens and improved CTC retrieval.
Illumina, Inc. (NextSeq 2000, NovaSeq 6000)
F. Hoffmann-La Roche Ltd (Cobas 6800 System, Elecsys Immunoassays)
PerkinElmer, Inc. (LabChip GX Touch, Epifluorescence Microscopes)
Agilent Technologies, Inc. (Agilent 2100 Bioanalyzer, Agilent SureSelect Target Enrichment)
Bio-Rad Laboratories, Inc. (Droplet Digital PCR System, QX200 ddPCR System)
Danaher Corporation (LabChip GXII Touch, Ion Torrent Next-Generation Sequencing)
Abbott (Alinity m System, i-STAT 1 Analyzer)
Thermo Fisher Scientific (Ion Proton System, Nanodrop Spectrophotometer)
Standard BioTools (BioFlux, Fluidic Card)
Life Technologies Corporation (Ion Proton System, QuantStudio 3D Digital PCR)
Fluidigm Corporation (Access Array System, Biomark HD System)
Qiagen N.V. (QIAxcel, QIAprep Spin Miniprep Kit)
Biomérieux (VIDAS, BioFire FilmArray)
Cellix Ltd. (VenaFlux, Cellix Fluidic Platform)
Elveflow (Elveflow OB1, Elveflow ELVE-HEART)
Micronit Micro Technologies B.V. (Microfluidic Chips, Lab-on-a-Chip Platforms)
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 27.86 Billion |
| Market Size by 2032 | USD 92.43 Billion |
| CAGR | CAGR of 14.29% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Application (Medical/Healthcare, Non-medical) • By Material (Silicon, Glass, Polymer, PDMS, Others) • By Technology (Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Illumina, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Abbott, Thermo Fisher Scientific, Standard BioTools, Life Technologies Corporation, Fluidigm Corporation, Qiagen N.V., Biomérieux, Cellix Ltd., Elveflow, Micronit Micro Technologies B.V. |
| Key Drivers | • Rising Chronic Disease Burden Propels Demand for Microfluidics Solutions in Healthcare • Expanding Applications of Microfluidics in Environmental and Food Safety Sectors |
| RESTRAINTS | • Technical Challenges Hindering Widespread Adoption of Microfluidics Technology |
Ans: Microfluidics Market was valued at USD 27.86 billion in 2023 and is expected to reach USD 92.43 billion by 2032, growing at a CAGR of 14.29% from 2024-2032.
Ans: The medical and healthcare sector dominated, accounting for about 85% of the market revenue.
Ans: Lab-on-a-chip (LOC) technology led the market in 2023 with around 38% of the revenue share.
Ans: North America dominated the market with a 42% revenue share in 2023.
Ans: The Asia-Pacific region is expected to grow at the highest CAGR of 17.48% from 2024 to 2032.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Microfluidics Market Segmentation, by Material
7.1 Chapter Overview
7.2 Silicon
7.2.1 Silicon Market Trends Analysis (2020-2032)
7.2.2 Silicon Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Glass
7.3.1 Glass Market Trends Analysis (2020-2032)
7.3.2 Glass Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Polymer
7.4.1 Polymer Market Trends Analysis (2020-2032)
7.4.2 Polymer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 PDMS
7.5.1 PDMS Market Trends Analysis (2020-2032)
7.5.2 PDMS Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.6.1 Others Market Trends Analysis (2020-2032)
7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Microfluidics Market Segmentation, by Application
8.1 Chapter Overview
8.2 Medical/Healthcare
8.2.1 Medical/Healthcare Market Trends Analysis (2020-2032)
8.2.2 Medical/Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 PCR & RT-PCR
8.2.3.1 PCR & RT-PCR Market Trends Analysis (2020-2032)
8.2.3.2 PCR & RT-PCR Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Gel Electrophoresis
8.2.4.1 Gel Electrophoresis Market Trends Analysis (2020-2032)
8.2.4.2 Gel Electrophoresis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Microarrays
8.2.5.1 Medical/Healthcare Market Trends Analysis (2020-2032)
8.2.5.2 Medical/Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.6 ELISA
8.2.6.1 ELISA Market Trends Analysis (2020-2032)
8.2.6.2 Medical/Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.7 Others
8.2.7.1 Others Market Trends Analysis (2020-2032)
8.2.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Non-medical
8.3.1 Non-medical Market Trends Analysis (2020-2032)
8.3.2 Non-medical Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Microfluidics Market Segmentation, by Technology
9.1 Chapter Overview
9.2 Lab-on-a-chip
9.2.1 Lab-on-a-chip Market Trends Analysis (2020-2032)
9.2.2 Lab-on-a-chip Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Organs-on-chips
9.3.1 Organs-on-chips Market Trends Analysis (2020-2032)
9.3.2 Organs-on-chips Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Continuous Flow Microfluidics
9.4.1 Continuous Flow Microfluidics Market Trends Analysis (2020-2032)
9.4.2 Continuous Flow Microfluidics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Optofluidics And Microfluidics
9.5.1 Optofluidics And Microfluidics Market Trends Analysis (2020-2032)
9.5.2 Optofluidics And Microfluidics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Acoustofluidics And Microfluidics
9.6.1 Acoustofluidics And Microfluidics Market Trends Analysis (2020-2032)
9.6.2 Acoustofluidics And Microfluidics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.7 Electrophoresis And Microfluidics
9.7.1 Electrophoresis And Microfluidics Market Trends Analysis (2020-2032)
9.7.2 Electrophoresis And Microfluidics Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.2.4 North America Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.2.6.2 USA Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.2.7.2 Canada Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.2.8.2 Mexico Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.6.2 Poland Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.7.2 Romania Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.4 Western Europe Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.6.2 Germany Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.7.2 France Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.8.2 UK Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.9.2 Italy Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.10.2 Spain Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.13.2 Austria Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.4 Asia Pacific Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.6.2 China Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.7.2 India Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.8.2 Japan Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.9.2 South Korea Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.10.2 Vietnam Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.11.2 Singapore Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.12.2 Australia Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.4 Middle East Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.6.2 UAE Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.2.4 Africa Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Microfluidics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.6.4 Latin America Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.6.6.2 Brazil Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.6.7.2 Argentina Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.6.8.2 Colombia Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Microfluidics Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Microfluidics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Microfluidics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 F. Hoffmann-La Roche Ltd
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 PerkinElmer, Inc
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Agilent Technologies, Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Teleflex Incorporated
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Danaher Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Abbott
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Standard BioTools
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Application
Medical/Healthcare
PCR & RT-PCR
Gel Electrophoresis
Microarrays
ELISA
Others
Non-medical
By Material
Silicon
Glass
Polymer
PDMS
Others
By Technology
Lab-on-a-chip
Organs-on-chips
Continuous Flow Microfluidics
Optofluidics And Microfluidics
Acoustofluidics And Microfluidics
Electrophoresis And Microfluidics
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The DNA Sequencing Market Size was valued at USD 11.5 Billion in 2023 and is expected to reach USD 52.1 Billion by 2032, growing at a CAGR of 17.8% Over the Forecast Period of 2024-2032.
The Nuclear Imaging Equipment Market was valued at USD 3.78 billion in 2023, and it is expected to reach USD 5.32 billion by 2032, registering a CAGR of 3.87% from 2024 to 2032.
The Podiatry Chairs Market was worth USD 1.08 billion in 2023 and is predicted to be worth USD 2.06 billion by 2032, growing at a CAGR of 7.46 % between 2024 and 2032.
The Pancreatic and Biliary Stents Market was valued at USD 354.2 Mn in 2023 and is expected to reach 511.47 Mn in 2031, and grow at a CAGR of 4.7% over the forecast period of 2024-2031.
The Multivitamin for Women Market Size was valued at USD 9.05 Billion in 2023, and is expected to reach USD 13.64 Billion by 2032, and grow at a CAGR of 4.83% over the forecast period 2024-2032.
The Population Health Management Market Size was valued USD 71.83 Bn in 2023, & will reach USD 352.55 Bn by 2031, and grow at a CAGR of 22.07% by 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
